Table 2 Values (median) of DOT and DDD in bloodstream infections treatment according to etiological factors
Etiology | DOT (days) | DDD |
|---|---|---|
Median (IQR) | Median (IQR) | |
Gram+ N = 452 | ||
Aminoglycosides | 7.0 (5.0; 9.0) | 0.109 (0.560; 0.180) |
Antimycotics | 12.0 (9.3; 16.0) | 0.195 (0.131; 0.341) |
Beta-lactams | 7.0 (5.0; 10.0) | 0.252 (0.180; 0.420) |
Glycopeptides | 10.0 (8.0; 11.0) | 0.128 (0.088; 0.168) |
Other | 9.0 (5.0; 15.0) | 0.211 (0.096; 0.452) |
Total | 9.0 (5.0; 15.0) | 0.140 (0.056; 0.453) |
Gram− N = 103 | ||
Aminoglycosides | 6.0 (4.3; 8.0) | 0.056 (0.036; 0.137) |
Antimycotics | 12.0 (8.2; 17.0) | 0.228 (0.131; 0.360) |
Beta-lactams | 8.0 (4.0; 11.0) | 0.244 (0.096; 0.448) |
Glycopeptides | 8.0 (4.0; 9.0) | 0.098 (0.039; 0.149) |
Other | 8.5 (5.3; 10.8) | 0.229 (0.099; 0.608) |
Total | 7.5 (4.0; 17.0) | 0.136 (0.036; 0.447) |
Changing N = 76 | ||
Aminoglycosides | 7.0 (5.0; 10.0) | 0.105 (0.061; 0.180) |
Antimycotics | 12.0 (10.0; 16.0) | 0.250 (0.158; 0.735) |
Beta-lactams | 7.0 (6.5; 11.0) | 0.281 (0.169; 0.495) |
Glycopeptides | 10.0 (7.0; 11.0) | 0.085 (0.056; 0.167) |
Other | 9.0 (6.0; 14.5) | 0.187 (0.120; 2.580) |
Total | 9.0 (5.0; 16.0) | 0.149 (0.056; 2.580) |
Candida N = 18 | ||
Aminoglycosides | 8.5 (4.8; 12.8) | 0.140 (0.070; 0.210) |
Antimycotics | 10.5 (9.0; 15.8) | 0.225 (0.092; 0.353) |
Beta-lactams | 12.0 (9.0; 19.5) | 450 (192.9; 2175) |
Glycopeptides | 10.0 (7.3; 10.8) | 0.087 (0.063; 0.161) |
Other | 13.5 (10.0; 17.0) | 3.276 (0.153; 6.400) |
Total | 10.0 (4.8; 19.5) | 0.164 (0.063; 6.400) |